JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schillaci, O.
Right arrow Articles by Madeddu, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schillaci, O.
Right arrow Articles by Madeddu, G.
Journal of Nuclear Medicine Vol. 44 No. 8 1219-1224
© 2003 by Society of Nuclear Medicine


Clinical Investigations

Mediastinal Lymph Node Involvement in Non–Small Cell Lung Cancer: Evaluation with 99mTc-Tetrofosmin SPECT and Comparison with CT

Orazio Schillaci, MD1, Angela Spanu, MD2, Francesco Scopinaro, MD3, Francesco Monteleone, MD3, Maria Elisabetta Solinas, MD2, Patrizia Volpino, MD4, Pietro Pirina, MD5, Pietro Marongiu, MD2, Vincenzo Cangemi, MD4 and Giuseppe Madeddu, MD2

1 Department of Diagnostic Imaging, University of Rome "Tor Vergata," Rome, Italy
2 Department of Nuclear Medicine, University of Sassari, Sassari, Italy
3 Department of Radiologic Sciences, University of Rome "La Sapienza," Rome, Italy
4 Department of Surgery, University of Rome "La Sapienza," Rome, Italy
5 Department of Respiratory Diseases, University of Sassari, Sassari, Italy

In patients with non–small cell lung cancer (NSCLC), surgical resection offers the best chance of cure. The preoperative assessment of mediastinal lymph node involvement is crucial to selecting those patients for whom surgery is indicated. Methods: To evaluate the possible clinical role of 99mTc-tetrofosmin scintigraphy in the presurgical detection of mediastinal node metastases from NSCLC, we performed a prospective comparative study with CT on 83 patients (48 men, 35 women; age range, 38–81 y) with primary NSCLC (36 adenocarcinomas, 39 epidermoid squamous cell carcinomas, and 8 large cell anaplastic carcinomas). They underwent chest SPECT 20 min after 99mTc-tetrofosmin injection (740 MBq intravenously). The metastatic involvement of mediastinal nodes was assessed by histologic examination after mediastinoscopy or thoracotomy. Both chest CT and 99mTc-tetrofosmin scintigraphy were performed within 2 wk before the surgical staging. Results: Metastatic mediastinal lymph nodes were found in 35 patients. 99mTc-Tetrofosmin imaging in assessing the mediastinal involvement yielded a sensitivity of 85.7%, a specificity of 89.6%, and an accuracy of 88.0%; CT results were 68.6%, 75.0%, and 72.3%, respectively. SPECT accuracy was significantly higher than CT accuracy (P < 0.05). However, precise anatomic localization of 99mTc-tetrofosmin uptake in the mediastinum was not always present on SPECT images. 99mTc-Tetrofosmin SPECT precisely detected the presence or absence of lymph node metastases in 33 of the 36 patients with positive CT findings (enlarged mediastinal nodes with a short axis >= 1 cm), with an accuracy (91.7%) significantly higher (P < 0.05) than that of CT (66.7%). Conclusion: 99mTc-Tetrofosmin SPECT is a useful presurgical noninvasive method to assess mediastinal lymph node involvement in NSCLC. In particular, it could play a clinical role in reducing the number of invasive staging surgical procedures in selected patients, especially in those with enlarged lymph nodes at CT. Fusing SPECT with CT images could further improve the interpretation of the scintigraphic data.

Key Words: non–small cell lung cancer • 99mTc-tetrofosmin • mediastinal lymph nodes • SPECT • CT




This article has been cited by other articles:


Home page
ChestHome page
G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck
Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 178S - 201S.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
L. H. Schwartz, J. A. C. Colville, M. S. Ginsberg, L. Wang, M. Mazumdar, J. Kalaigian, H. Hricak, D. Ilson, and G. K. Schwartz
Measuring tumor response and shape change on CT: esophageal cancer as a paradigm
Ann. Onc., June 1, 2006; 17(6): 1018 - 1023.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. Shiraishi, S. Tomiguchi, D. Utsunomiya, K. Kawanaka, K. Awai, S. Morishita, T. Okuda, K. Yokotsuka, and Y. Yamashita
Quantitative Analysis and Effect of Attenuation Correction on Lymph Node Staging of Non-Small Cell Lung Cancer on SPECT and CT.
Am. J. Roentgenol., May 1, 2006; 186(5): 1450 - 1457.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
D R Baldwin, J D Birchall, R H Ganatra, and K S Pointon
Evaluation of the solitary pulmonary nodule: clinical management, role of CT and nuclear medicine
Imaging, October 1, 2004; 16(1): 22 - 36.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.